Evidence map›Paper›PMID 19107841›Full record

ArticleJournal of cellular physiology2009

Endogenous FGF-2 is critically important in PTH anabolic effects on bone.

Maria Giovanna Sabbieti, Dimitrios Agas, Liping Xiao, Luigi Marchetti, J Douglas Coffin, Thomas Doetschman, Marja M Hurley

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. FGF family in health and disease.Molecular biomedicine · 2026
    Review
  2. Incomplete lineage sorting shaped mixed traits during a colobine primate radiation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. The Hematopoietic Bone Marrow Niche Ecosystem.Frontiers in cell and developmental biology · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2012
    Article
  20. Osteoporotic fracture and parathyroid hormone.World journal of orthopedics · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Maria Giovanna SabbietiDepartment of Comparative Morphology and Biochemistry, University of Camerino, Camerino (MC), Italy.
Dimitrios Agas
Liping Xiao
Luigi Marchetti
J Douglas Coffin
Thomas Doetschman
Marja M Hurley
Università di Camerino · ITUConn Health · USUniversity of Arizona · USUniversity of Montana · US

Funding

Action of Anbolic Factors on Bone Formation in MiceR01AG021189 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HURLEY, MARJA MARIE · 2004 to 2013
$2.5M
NIA NIH HHS AG021189NIA NIH HHS R01 AG021189
6 · The paper itself

Abstract

Parathyroid hormone (PTH) increases fibroblast growth factor receptor-1 (FGFR1) and fibroblast growth factor-2 (FGF-2) expression in osteoblasts and the anabolic response to PTH is reduced in Fgf2-/- mice. This study examined whether candidate factors implicated in the anabolic response to PTH were modulated in Fgf2-/- osteoblasts. PTH increased Runx-2 protein expression in Fgf2+/+ but not Fgf2-/- osteoblasts. By immunocytochemistry, PTH treatment induced nuclear accumulation of Runx-2 only in Fgf2+/+ osteoblasts. PTH and FGF-2 regulate Runx-2 via activation of the cAMP response element binding proteins (CREBs). Western blot time course studies showed that PTH increased phospho-CREB within 15 min that was sustained for 24 h in Fgf2+/+ but had no effect in Fgf2-/- osteoblasts. Silencing of FGF-2 in Fgf2+/+ osteoblasts blocked the stimulatory effect of PTH on Runx-2 and CREBs phosphorylation. Studies of the effects of PTH on proteins involved in osteoblast precursor proliferation and apoptosis showed that PTH increased cyclinD1-cdk4/6 protein in Fgf2+/+ but not Fgf2-/- osteoblasts. Interestingly, PTH increased the cell cycle inhibitor p21/waf1 in Fgf2-/- osteoblasts. PTH increased Bcl-2/Bax protein ratio in Fgf2+/+ but not Fgf2-/- osteoblasts. In addition PTH increased cell viability in Fgf2+/+ but not Fgf2-/- osteoblasts. These data suggest that endogenous FGF-2 is important in PTH effects on osteoblast proliferation, differentiation, and apoptosis. Reduced expression of these factors may contribute to the reduced anabolic response to PTH in the Fgf2-/- mice. Our results strongly indicate that the anabolic PTH effect is dependent in part on FGF-2 expression.

Indexed as

Anabolic AgentsAnimalsbcl-2-Associated X ProteinCells, CulturedCore Binding Factor Alpha 1 SubunitCyclic AMP Response Element-Binding ProteinCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Extracellular Signal-Regulated MAP KinasesFibroblast Growth Factor 2HumansMiceMice, KnockoutOsteoblastsParathyroid HormoneProto-Oncogene Proteins c-bcl-2Anabolic AgentsBax protein, mousebcl-2-Associated X ProteinCdk4 protein, mouseCdk6 protein, mouseCore Binding Factor Alpha 1 SubunitCyclic AMP Response Element-Binding ProteinCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Extracellular Signal-Regulated MAP KinasesFibroblast Growth Factor 2Parathyroid HormoneProto-Oncogene Proteins c-bcl-2RNA, Small InterferingRunx2 protein, mouse

Identifiers

PMID19107841
PMCPMC2763338
OpenAlexW2046433022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.